Acuitas Investments, LLC
SEATTLE, WA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 6, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$2.6M2026 Q3
Positions13
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.98.6%
Top Holdings
BMRN
Biomarin Pharmaceutical
16.5%
SLB
SLB
15.7%
FSLR
First Solar
15.1%
GMED
Globus Medical
11.7%
UAN
CVR Partners
11.7%
NFGC
New Found Gold
10.9%
BIDU
Baidu
5.4%
MCHX
Marchex
5.2%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.